Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Finasteride, originally for prostate issues, also treats hair loss, similar to effects from certain plants.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Finasteride use may be linked to rare testicular tumor, but more research needed.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

The methods accurately measure finasteride and tadalafil in Entadfi™ capsules for quality control.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Purple corn extract may help reduce prostate enlargement and inflammation.

New treatments targeting fibrosis could improve urinary symptoms in BPH.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.